MediFind
LoginSign Up
Are we missing a condition or feature you’d like to see? MediFind is always evolving and we’d love your feedback.
MediFind
Condition

Adrenoleukodystrophy

Symptoms, Doctors, Treatments, Research & More

Active Clinical Trials

Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 50
  • Start Date: August 20, 2020
A Prospective Outcomes Study of Pediatric and Adult Patients With Non-Malignant Disorders Undergoing Umbilical Cord Blood, Bone Marrow, or Peripheral Blood Stem Cell Transplantation With a Reduced-Intensity Conditioning Regimen (PRO-RIC)
Clinical Trial
Drug
  • Status: Not yet recruiting
  • Study Type: Drug
  • Participants: 5
  • Start Date: March 9, 2020
Effect of Plasma Exchange With Albumin in Patients With Adrenomyeloneuropathy: Unicentric, Single Arm, Proof of Concept Study.
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 13
  • Start Date: September 13, 2019
An Open-label, Multicenter Study in Male Pediatric Patients With Cerebral X-linked Adrenoleukodystrophy (Cald) to Assess the Effects of MIN-102 Treatment on Disease Progression Prior to Human Stem Cell Transplant (HSCT)
Clinical Trial
Other
  • Status: Active, not recruiting
  • Study Type: Other
  • Participants: 3
  • Start Date: May 21, 2019
A Follow-Up Study to Evaluate the Safety and Clinical Outcomes of Patients With Non-Malignant Disease Who Have Undergone Hematopoietic Stem Cell Transplantation With MGTA-456
Clinical Trial
Other
  • Status: Recruiting
  • Study Type: Other
  • Participants: 1000
  • Start Date: May 1, 2019
Adrenoleukodystrophy National Registry Study
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 35
  • Start Date: January 24, 2019
A Phase 3 Study of Lenti-D Drug Product After Myeloablative Conditioning Using Busulfan and Fludarabine in Subjects ≤17 Years of Age With Cerebral Adrenoleukodystrophy (CALD)
Clinical Trial
Other
  • Status: Recruiting
  • Participants: 60
  • Start Date: December 17, 2018
Evaluation of a New Strategy for the Diagnosis of Peroxisomal Diseases
Clinical Trial
Genetic
  • Status: Recruiting
  • Study Type: Genetic
  • Participants: 10
  • Start Date: October 30, 2018
Lentiviral Gene Therapy for X-linked Adrenoleukodystrophy (X-ALD)
Clinical Trial
Other
  • Status: Recruiting
  • Participants: 100
  • Start Date: February 16, 2018
A Non-interventional Study to Prospectively Assess Baseline Status and Disease Progression in Male Children With X-Linked Adrenoleukodystrophy
Clinical Trial
Drug
  • Status: Active, not recruiting
  • Study Type: Drug
  • Participants: 8
  • Start Date: February 9, 2018
A Phase 2, Single-arm, Open-label Study to Evaluate the Safety and Efficacy of MGTA-456 in Patients With Inherited Metabolic Disorders (IMD) Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Clinical Trial
Drug
  • Status: Active, not recruiting
  • Study Type: Drug
  • Participants: 105
  • Start Date: December 8, 2017
A Randomized, Double-blind, Placebo-controlled, Multinational, Multicenter Study With Open-label Treatment Extension to Assess the Effect of MIN-102 (IMP) on the Progression of Adrenomyeloneuropathy in Male Patients With X-linked Adrenoleukodystrophy
Clinical Trial
Dietary Supplement
  • Status: Active, not recruiting
  • Study Type: Dietary Supplement
  • Participants: 21
  • Start Date: March 2016
A Pilot Study of Vitamin D in Boys With X-linked Adrenoleukodystrophy
Showing 1–12 of 18 Clinical Trials
Next